Kelley Boucher serves as Executive at Apellis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Kelley Boucher has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 28, 2026 involved receiving (via award) 30,146 shares valued at $0.
Kelley Boucher currently holds 127,804 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kelley Boucher has been a net neutral trader of APLS stock. They have purchased $0 and sold $0 worth of shares.
Kelley Boucher's most recent insider trade was on Jan 28, 2026, when they sold 30,146 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |